Xeris Biopharma Holdings, Inc. (XERS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.59
Day's range
$5.82

Xeris Biopharma Holdings Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 12.64 M $99.22 M   5.97% 7.12%
VANGUARD GROUP INC 01/29/2026 11.19 M $87.82 M   13.83% 6.30%
D. E. SHAW & CO., INC. 02/17/2026 7.57 M $59.46 M   29.71% 4.26%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 4.28 M $33.57 M   3.28% 2.41%
STATE STREET CORP 02/13/2026 4.12 M $32.32 M   10.13% 2.32%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 3.50 M $27.46 M   6.82% 1.97%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/17/2026 2.98 M $23.40 M   13.80% 1.68%
NUVEEN, LLC 02/12/2026 2.81 M $22.03 M   -0.75% 1.58%
MORGAN STANLEY 02/13/2026 2.71 M $21.26 M   -15.90% 1.52%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 2.29 M $17.95 M   293.59% 1.29%
ROSALIND ADVISORS, INC. 02/12/2026 2.11 M $16.58 M   17.59% 1.19%
TWO SIGMA INVESTMENTS, LP 02/17/2026 1.73 M $13.60 M   7.31% 0.98%
PARKMAN HEALTHCARE PARTNERS LLC 02/17/2026 1.69 M $13.28 M   -5.59% 0.95%
GOLDMAN SACHS GROUP INC 03/25/2026 1.57 M $12.31 M   -12.64% 0.88%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.40 M $11.02 M   -2.96% 0.79%
LEGAL & GENERAL GROUP PLC 02/09/2026 1.40 M $10.95 M   2.86% 0.79%
CENTERBOOK PARTNERS LP 02/11/2026 1.39 M $10.92 M   99.31% 0.78%
NORTHERN TRUST CORP 02/17/2026 1.39 M $10.89 M   1.74% 0.78%
GRANAHAN INVESTMENT MANAGEMENT, LLC 02/17/2026 1.22 M $9.60 M   249.38% 0.69%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2026 1.21 M $9.53 M   0.20% 0.68%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 1.06 M $8.31 M   -37.68% 0.60%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 971.60 K $7.62 M   5.48% 0.55%
KNOTT DAVID M JR 02/12/2026 970.00 K $7.61 M   -4.43% 0.55%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 957.58 K $7.52 M   -2.65% 0.54%
DEUTSCHE BANK AG\ 02/11/2026 940.59 K $7.38 M   -40.00% 0.53%
JPMORGAN CHASE & CO 02/11/2026 895.06 K $7.03 M   -1.11% 0.50%
MILLENNIUM MANAGEMENT LLC 02/17/2026 859.05 K $6.74 M   63.71% 0.48%
FEDERATED HERMES, INC. 02/12/2026 854.89 K $6.71 M   21.37% 0.48%
TWO SIGMA ADVISERS, LP 02/17/2026 849.33 K $6.67 M   -4.92% 0.48%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/17/2026 811.13 K $6.37 M   -21.60% 0.46%
NORGES BANK 02/10/2026 800.70 K $6.29 M   100.00% 0.45%
02/17/2026 800.00 K $6.28 M   100.00% 0.45%
ESSEX INVESTMENT MANAGEMENT CO LLC 02/13/2026 734.53 K $5.77 M   -2.07% 0.41%
ALGERT GLOBAL LLC 02/17/2026 718.84 K $5.64 M   355.08% 0.40%
BANK OF AMERICA CORP /DE/ 02/17/2026 717.91 K $5.64 M   -54.99% 0.40%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 651.45 K $5.11 M   255.09% 0.37%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 619.66 K $4.86 M   -61.82% 0.35%
PRUDENTIAL FINANCIAL INC 02/13/2026 618.95 K $4.86 M   -56.84% 0.35%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 608.08 K $4.77 M   100.00% 0.34%
UBS GROUP AG 01/29/2026 601.83 K $4.72 M   -66.24% 0.34%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 02/13/2026 537.48 K $4.22 M   111.61% 0.30%
SQUAREPOINT OPS LLC 02/13/2026 482.83 K $3.79 M   -28.90% 0.27%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 458.33 K $3.60 M   14.56% 0.26%
CASTLEARK MANAGEMENT LLC 02/13/2026 445.95 K $3.50 M   100.00% 0.25%
FMR LLC 02/17/2026 439.71 K $3.45 M   22.08% 0.25%
BANK OF NEW YORK MELLON CORP 02/10/2026 434.26 K $3.41 M   -1.27% 0.24%
CITADEL ADVISORS LLC 02/17/2026 409.82 K $3.22 M   -6.35% 0.23%
SEI INVESTMENTS CO 02/13/2026 399.35 K $3.13 M   229.56% 0.22%
CANADA PENSION PLAN INVESTMENT BOARD 02/17/2026 390.60 K $3.07 M   3.97% 0.22%
VOSS CAPITAL, LLC 02/13/2026 371.71 K $2.92 M   16.23% 0.21%

Xeris Biopharma Holdings Inc institutional Ownership - FAQ's

During the previous two years, 289 institutional investors and hedge funds held shares of Xeris Biopharma Holdings Inc. The most heavily invested institutionals were:

Nuveen, LLC: 2.92 M

UBS Group AG: 1.65 M

CenterBook Partners LP: 1.25 M

Bank of New York Mellon Corp: 426,285

Apella Capital, LLC: 235,897

PRINCIPAL FINANCIAL GROUP INC: 208,507

56.76% of Xeris Biopharma Holdings Inc stock is owned by institutional investors.

Institutional investors have bought a total of 116.63 M shares in the last 24 months. This purchase volume represents approximately $653.15 M in transactions.